For instance, IFI16 has demonstrated anti-tumour effects in triple-negative breast cancer by inducing STING-mediated IFN-I production (Ka et al., 2021; Huang et al., 2022). The gene discussed is STING1; the disease is triple-negative breast carcinoma.